An impairment of action of the incretin hormones has been identified as an early and specific characteristic of type-2 diabetes mellitus (T2DM) and is likely to be due to a loss of response to the incretin hormones at the pancreatic β-cell [6]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.